赛升药业(300485) - 2025年度财务决算报告

| 项目 | 2025 年末 | 2024 年末 | 增减比例 | | --- | --- | --- | --- | | 货币资金 | 88,134,170.56 | 75,262,690.31 | 17.10% | | 交易性金融资产 | 1,473,900,144.47 | 1,496,350,629.65 | -1.50% | | 应收票据 | 2,476,306.12 | 3,432,332.03 | -27.85% | | 应收账款 | 42,398,681.03 | 47,320,922.37 | -10.40% | | 预付款项 | 19,713.80 | 130,457.75 | -84.89% | | 其他应收款 | 948,161.59 | 1,434,421.68 | -33.90% | | 存货 | 68,850,757.57 | 81,369,540.32 | -15.39% | | 其他流动资产 | 10,802,498.14 | 6,342,903.15 | 70.31% | | 长期股权投资 | 709,580,877.36 | 706,402,153.78 | 0.45% ...